These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7070696

  • 1. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V, Attisano N, Sarica G, Grenci G, Martelli G.
    Minerva Med; 1982 Apr 02; 73(14):845-9. PubMed ID: 7070696
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V, Attisano N, Sarica G, Grenci G, Martelli G.
    Boll Soc Ital Cardiol; 1981 Apr 02; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract] [Full Text] [Related]

  • 3. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
    Buch J, Rasmussen S.
    Cor Vasa; 1983 Apr 02; 25(5):358-66. PubMed ID: 6653128
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG, Mancini A, Brignole M, Astengo D, Bertulla A.
    Minerva Cardioangiol; 1981 Dec 02; 29(12):719-28. PubMed ID: 7038536
    [No Abstract] [Full Text] [Related]

  • 5. Hypertension in general practice: a comparative study of labetalol and metoprolol (+/- prazosin) in general practice.
    Piterman L.
    Aust Fam Physician; 1981 Jul 02; 10(7):579-83. PubMed ID: 7283872
    [No Abstract] [Full Text] [Related]

  • 6. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ, Louis WJ.
    Br J Clin Pharmacol; 1979 Jul 02; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [Abstract] [Full Text] [Related]

  • 7. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol].
    Rossi A, Ziacchi V, Lomanto B.
    Arch Mal Coeur Vaiss; 1979 Nov 02; 72(11):1240-6. PubMed ID: 121529
    [Abstract] [Full Text] [Related]

  • 8. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG, Hunter J, Lees CD, Millar JA, Brown JJ, Robertson JI.
    Br J Clin Pharmacol; 1979 Nov 02; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment of hypertension with labetalol.
    Prichard BN, Boakes AJ, Hernández R.
    Br J Clin Pharmacol; 1979 Nov 02; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [Abstract] [Full Text] [Related]

  • 10. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM, Spencer M.
    Br J Clin Pharmacol; 1979 Nov 02; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of labetalol in essential hypertension. Effects of long-term treatment in conditions of rest and stress].
    Rossi A, Ziacchi V, Lomanto B.
    Minerva Cardioangiol; 1980 Sep 02; 28(9):637-44. PubMed ID: 7007921
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of metoprolol on myocardial performance in hypertensive patients during exercise (author's transl)].
    Ferro G, Ricciardelli B, Volpe M, Tari M, Trimarco B, Rengo F, Condorelli M.
    G Ital Cardiol; 1980 Sep 02; 10(9):1171-8. PubMed ID: 7461366
    [Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M, Ansuini R, Pupita G, Campolucci G, Pupita F.
    Int J Clin Pharmacol Res; 1984 Sep 02; 4(5):385-7. PubMed ID: 6519853
    [Abstract] [Full Text] [Related]

  • 14. [The effects of metoprolol on systolic times in patients with systemic arterial hypertension. Polygraphic study].
    Schirripa V, Attisano N, Sarica G, Grenci G, Martelli G.
    Minerva Med; 1982 Jan 14; 73(1-2):71-5. PubMed ID: 7058006
    [Abstract] [Full Text] [Related]

  • 15. Labetalol in long-term treatment of hypertension.
    Prichard BN, Boakes AJ.
    Br J Clin Pharmacol; 1976 Aug 14; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [Abstract] [Full Text] [Related]

  • 16. [Effects of metoprolol and a combination of metoprolol and hydrochlorothiazide on arterial tension values in hypertensive patients at rest and following exertion. Crossed double-blind study].
    Novo S, Davì G, Avellone G, Fazio M, Micci S, Modica R, Buzzetti G.
    Boll Soc Ital Cardiol; 1981 Aug 14; 26(2):117-29. PubMed ID: 7337767
    [No Abstract] [Full Text] [Related]

  • 17. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD, Joekes AM, Hussein MM.
    Br J Clin Pharmacol; 1979 Aug 14; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [Abstract] [Full Text] [Related]

  • 18. [Ergometric control in hypertension treatment with labetalol].
    Prohaska H, Honetz N.
    Wien Med Wochenschr Suppl; 1981 Aug 14; 69():20-2. PubMed ID: 6952661
    [No Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of atenolol and labetalol in essential hypertension--a double blind cross over trial.
    Srivastava SC, Jagdish, Katyal VK, Singh H, Mohan R.
    Indian Heart J; 1989 Aug 14; 41(4):256-60. PubMed ID: 2807362
    [Abstract] [Full Text] [Related]

  • 20. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH, Michelson EL, Johnson BF, Poland MP.
    Am J Med; 1983 Oct 17; 75(4A):54-67. PubMed ID: 6356900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.